Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
Trishula Therapeutics, Inc.
Institut Bergonié
University of Virginia
Rutgers, The State University of New Jersey
City of Hope Medical Center
Incyte Corporation
Institut Bergonié
University of South Florida
Institut Bergonié
Masonic Cancer Center, University of Minnesota
Amgen
Amgen
University of Arizona
Columbia University
Barbara Ann Karmanos Cancer Institute
Altor BioScience
Northside Hospital, Inc.